Amrutanjan Health Care
635.05
+52.35(+8.98%)
Market Cap₹1,835.97 Cr
PE Ratio29.63
IndustryHealthcare
Company Performance:
1D+8.98%
1M-5.60%
6M-6.56%
1Y-4.22%
5Y+22.25%
View Company Insightsright
More news about Amrutanjan Health Care
15May 25
Amrutanjan Health Care Reports Strong Q4 Results, Announces Dividend
Amrutanjan Health Care's Q4 financial results show significant growth. Revenue increased by 6.30% to ₹1.35 billion, while net profit rose by 11.13% to ₹151.80 million. EBITDA improved to ₹177.00 million with a margin of 13.07%. The company also announced a final dividend of ₹2.60 per equity share, reflecting confidence in its financial position and commitment to shareholder value.
 no imag found
Amrutanjan Health Care
635.05
+52.35
(+8.98%)
1 Year Returns:-4.22%
Industry Peers
Sun Pharmaceutical
1,704.40
(+0.14%)
Divis Laboratories
6,054.50
(-2.49%)
Torrent Pharmaceuticals
4,023.50
(-0.55%)
Cipla
1,326.70
(+0.29%)
Dr Reddys Laboratories
1,240.20
(+0.39%)
Lupin
2,195.20
(+0.43%)
Zydus Life Science
905.25
(+0.26%)
Mankind Pharma
2,089.30
(-3.39%)
Aurobindo Pharma
1,212.70
(-1.09%)
Alkem Laboratories
5,653.50
(-0.86%)